Published in:
Nephron Experimental Nephrology, 9 (2001) 6, Seite 436-443
Language:
English
DOI:
10.1159/000052643
ISSN:
1660-2129
Origination:
Footnote:
Description:
Podocyte function appears to be regulated by vasoactive factors. In vivo podocytes express parathyroid hormone-related protein (PTHrP), the N-terminal fragment of which has vasoactive properties. Since the signaling pathway(s) of PTHrP(1–36) are unknown in podocytes, differentiated cells of a conditionally immortalized mouse podocyte cell line were studied. Gene expression of PTHrP and the PTH/PTHrP receptor was investigated by RT-PCR; protein distribution of PTHrP was examined by immunofluorescence. Accumulation of cAMP was determined by an enzyme immunoassay; [Ca<sup>2+</sup>]<sub>i</sub> was measured by fura-2 ratio imaging. PTHrP and PTH/PTHrP receptor mRNA was detected in differentiated podocytes. Immunoreactive PTHrP exhibited a granular distribution in the cytoplasm of differentiated podocytes. With regard to the signaling pathway(s) of PTHrP(1–36), a concentration-dependent increase of cAMP levels with an EC<sub>50</sub> value of 4 ± 2 n<i>M</i> was found. PTHrP(1–36) (1 µ<i>M</i>) increased cAMP levels 5.5 ± 1.1-fold above baseline as compared with a 25.4 ± 4.2-fold increase in response to forskolin (10 µ<i>M</i>). The PTH/PTHrP receptor antagonist PTHrP(7–34) significantly diminished the PTHrP(1–36)-induced cAMP increase. While superfusion of podocytes with bradykinin (100 n<i>M</i>) increased [Ca<sup>2+</sup>]<sub>i</sub>, PTHrP(1–36) (100 n<i>M</i>) was without effect on [Ca<sup>2+</sup>]<sub>i</sub>. However, PTHrP(1–36) attenuated the bradykinin-induced increase in [Ca<sup>2+</sup>]<sub>i</sub>. Our results suggest that PTHrP is an autocrine hormone in podocytes, which selectively activates the cAMP pathway through the PTH/PTHrP receptor.